CAREDX INC (CDNA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CDNA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CDNA | Director | 70 | [] | ["Audit and Finance Committee","Governance and Nominating Committee","Compensation and Human Capital Committee","Technology and Innovation Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INVA | Director | 66 | [] | [] | 2022 |
Biography sourced from the proxy statement filing.
Independent Director Age: 70 Independent Director since 2014 Committees: Audit & Finance Committee Governance & Nominating Committee Compensation & Human Capital Committee Professional Experience Partner & MD, M.M. Dillon & Co. (2005 - Present) CFO, Novartis Pharma AG (2000 - 2005) EVP & CFO, Workspace (1999 - 2000) EVP & CFO, Uniscribe Professional Services (1998 - 1999) EVP & CFO, Intellisource Group (1998) Vice President (Finance), Cognizant (1997) CFO, IMS Health (1990 - 1997) Senior Vice President (Finance), Dun & Bradstreet (NYSE: DNB) (1985 1989) Auditor & Engineer, General Electric (1978 - 1984) Key Skills & Qualifications Mr. Bickerstaff was selected to serve on the Board based on his extensive experience in financial leadership, healthcare operations, and public company governance. He has served as Chief Financial Officer for multiple global healthcare and life sciences organizations and has significant expertise in financial reporting, capital markets, mergers and acquisitions, and risk management. Mr. Bickerstaff also brings substantial experience in public company board service, including audit, finance, and governance oversight at publicly traded biotechnology and healthcare companies. The Board believes his background provides valuable perspective in overseeing financial integrity, strategic transactions, and regulatory risk. Other Boards Director, InCarda Therapeutics (2020 - 2023) Director, Innoviva (Nasdaq: INVA) (2017 - 2023) Director, RoosterBio (2017 - 2020) Chairman, Optical Academy (2017 - 2019) Independent Chairman, Cardax (2016 - 2021) Director, Aegis Health Analytics (2014 - 2016) Director, Sio Gene Therapies (Nasdaq: SIOX) (2018 - 2020) Director, Inovio Pharmaceuticals (Nasdaq: INO) (2017 - 2018) Director, Ariad Pharmaceuticals (Nasdaq: ARIA) (2016 - 2017) Director, Viventia Bio Inc. (2015 - 2017) Director, Cyclica Inc. (2010 - 2014) Director, BMP Sunstone (Nasdaq: BJGP) (2008 - 2009) Director, Vion Pharmaceuticals (Nasdaq: VION) (2005 - 2008) Director, Amazys Holding (2005 - 2006) Current Organizations Founding Member, The Global Leaders Chairman, International Vaccine Institute Previous Organizations Vice Chairman, International Centre for Missing & Exploited Children Chairman, Global Oncology Director, Center for Disease Dynamics, Economics & Policy Inc. Director, Gavi, the Vaccine Alliance Education B.S., Rutgers University B.A., Rutgers University